Study S001953

Treatment With Glucagon-Like Peptide-1 Receptor, Exenatide, in Patients With Diabetes and Heart Failure With Normal Left Ventricular Ejection Fraction

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT00799435
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: TERMINATED
Enrollment: 2
Start: 2009-07
Primary completion: 2012-04
Lead sponsor: Baylor College of Medicine
Conditions: Diabetes Mellitus, Type 2; Heart Failure, Diastolic
Interventions: DRUG:Exenatide
Results posted: TRUE
Individual participant data sharing: NO
Secondary identifiers: NIH:1K01HL092585; NIH:1K01HL092585-01; OTHER:H-22906

Registered primary outcomes

Change in Aortic Stiffness, as Measured by the Change in the Mean Aortic Pulse Wave Velocity [Measured at Week 12]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.